Regeneron Pharmaceuticals Inc
XBER:RGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regeneron Pharmaceuticals Inc
XBER:RGO
|
US |
Wall St Price Targets
RGO Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RGO is 177.67 EUR with a low forecast of 135.79 EUR and a high forecast of 220.24 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
177.67
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 177.67 EUR with a low forecast of 135.79 EUR and a high forecast of 220.24 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
23%
The compound annual growth rate for Operating Income over the next 3 years is 23%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 15%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Net Income over the next 3 years is 15%.
